Center Laboratories, Inc. (TPEX:4123)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
43.75
-0.90 (-2.02%)
At close: Mar 13, 2026
Market Cap32.66B +10.4%
Revenue (ttm)1.52B -6.3%
Net Income9.32B
EPS11.44
Shares Out746.53M
PE Ratio3.82
Forward PEn/a
Dividend0.71 (1.63%)
Ex-Dividend DateOct 3, 2025
Volume2,900,435
Average Volume9,265,409
Open44.20
Previous Close44.65
Day's Range43.65 - 44.65
52-Week Range29.12 - 51.40
Beta0.35
RSI51.35
Earnings DateMar 17, 2026

About Center Laboratories

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretics and analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. It also offers central nervous system medication consisting of treatments for cerebrovascular disease, deme... [Read more]

Sector Healthcare
Founded 1959
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4123
Full Company Profile

Financial Performance

Financial Statements